Log on / register
Feedback | Support | My details
CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.
Chang JH, Gertig DM, Chen X, Dite GS, Jenkins MA, Milne RL, Southey MC, McCredie MR, Giles GG, Chenevix-Trench G, Hopper JL, Spurdle AB
Breast Cancer Res 2005, 7:R513-21
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Commentary    
CYP17 and breast cancer: no overall effect, but what about interactions?
Little J, Simard J
Breast Cancer Research 2005, 7:238-242 (20 September 2005)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

2.


Research article    
CYP17 gene polymorphism in relation to breast cancer risk: a case-control study
Einarsdóttir K, Rylander-Rudqvist T, Humphreys K, Ahlberg S, Jonasdottir G, Weiderpass E, Chia KS, Ingelman-Sundberg M, Persson I, Liu J, Hall P, Wedrén S
Breast Cancer Research 2005, 7:R890-R896 (14 September 2005)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.